The ratio of ER-α to ER-β is a prognostic marker in breast tumors, such that ER-β expression is indicative of more benign tumors, whereas ER-α indicates malignant, aggressive tumors (Balfe et al. 2004; Shaaban et al. 2003). The gene discussed is ESR2; the disease is breast neoplasm.